TACR1 and glioblastoma: The current standard of care for glioblastoma, known as the Stupp protocol, combines surgical resection with concomitant radiotherapy and temozolomide, yet prognosis remains poor—highlighting the need for novel therapeutic strategies such as NK‐1R antagonism [11].